Replimune (REPL) Operating Leases (2018 - 2026)
Replimune (REPL) reported Operating Leases of $2.3 million for Q1 2026, down 24.32% on a YoY basis from $3.1 million in Q1 2025, and down 37.54% sequentially from $3.7 million in Q4 2025.
Replimune (REPL) Operating Leases (2018 - 2026) Analysis & Trends
Replimune (REPL) has 9 years of Operating Leases data on file, last reported at $2.3 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases fell 24.32% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (down 24.32% YoY), and the FY2026 full-year result was $2.3 million, down 24.32% from the prior year.
- Operating Leases declined to $2.3 million in Q1 2026, from $3.7 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $32.8 million in Q1 2022 to a low of $2.3 million in Q1 2026.
- A 5-year average of $10.6 million and a median of $4.4 million in 2023 frame the typical range for Operating Leases.
- Peak annual rise in Operating Leases reached 637.78% in 2023, while the deepest fall reached 86.63% in 2023.
- Tracing REPL's Operating Leases over 5 years: stood at $4.3 million in 2022, then surged by 635.69% to $31.4 million in 2023, then tumbled by 86.01% to $4.4 million in 2024, then dropped by 15.08% to $3.7 million in 2025, then plunged by 37.54% to $2.3 million in 2026.
- Business Quant data shows REPL's Operating Leases at $2.3 million in Q1 2026, $3.7 million in Q4 2025, and $3.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.33 Mn |
| Dec 31, 2025 | 3.73 Mn |
| Sep 30, 2025 | 3.93 Mn |
| Jun 30, 2025 | 2.95 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Dec 31, 2024 | 4.39 Mn |
| Sep 30, 2024 | 4.70 Mn |
| Jun 30, 2024 | 4.76 Mn |
| Mar 31, 2024 | 3.77 Mn |
| Dec 31, 2023 | 31.38 Mn |
| Sep 30, 2023 | 31.58 Mn |
| Jun 30, 2023 | 5.43 Mn |
| Mar 31, 2023 | 4.39 Mn |
| Dec 31, 2022 | 4.27 Mn |
| Sep 30, 2022 | 4.28 Mn |
| Jun 30, 2022 | 32.47 Mn |
| Mar 31, 2022 | 32.84 Mn |
| Dec 31, 2021 | 6.05 Mn |
| Sep 30, 2021 | 4.82 Mn |
| Jun 30, 2021 | 4.98 Mn |